Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies von D’Antonio, Chiara, Passaro, Antonio, Gori, Bruno, Del Signore, Ester, Migliorino, Maria Rita, Ricciardi, Serena, Fulvi, Alberto, de Marinis, Filippo

Volltext

Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development von Corvaja, Carla, Passaro, Antonio, Attili, Ilaria, Aliaga, Pamela Trillo, Spitaleri, Gianluca, Signore, Ester Del, de Marinis, Filippo

Volltext

Surgery for small cell lung cancer: When and how von Casiraghi, Monica, Sedda, Giulia, Del Signore, Ester, Piperno, Gaia, Maisonneuve, Patrick, Petrella, Francesco, de Marinis, Filippo, Spaggiari, Lorenzo

Volltext

Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review von Attili, Ilaria, Passaro, Antonio, Corvaja, Carla, Trillo Aliaga, Pamela, Del Signore, Ester, Spitaleri, Gianluca, de Marinis, Filippo

Volltext

Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer von Catania, Chiara, Passaro, Antonio, Rocco, Elena Guerini, Spitaleri, Gianluca, Barberis, Massimo, Noberasco, Cristina, Signore, Ester del, Travaini, Laura, de Marinis, Filippo

Volltext

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations von Attili, Ilaria, Corvaja, Carla, Spitaleri, Gianluca, Del Signore, Ester, Trillo Aliaga, Pamela, Passaro, Antonio, de Marinis, Filippo

Volltext

Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings von Attili, Ilaria, Corvaja, Carla, Spitaleri, Gianluca, Trillo Aliaga, Pamela, Del Signore, Ester, Passaro, Antonio, de Marinis, Filippo

Volltext

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target von Spitaleri, Gianluca, Trillo Aliaga, Pamela, Attili, Ilaria, Del Signore, Ester, Corvaja, Carla, Corti, Chiara, Uliano, Jacopo, Passaro, Antonio, de Marinis, Filippo

Volltext

Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs" von Spitaleri, Gianluca, Trillo Aliaga, Pamela, Attili, Ilaria, Del Signore, Ester, Corvaja, Carla, Pellizzari, Gloria, Katrini, Jalissa, Passaro, Antonio, de Marinis, Filippo

Volltext

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey von Catania, Chiara, Spitaleri, Gianluca, Del Signore, Ester, Attili, Ilaria, Radice, Davide, Stati, Valeria, Gianoncelli, Letizia, Morganti, Stefania, de Marinis, Filippo

Volltext

Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials von Attili, Ilaria, Fuorivia, Valeria, Spitaleri, Gianluca, Corvaja, Carla, Trillo Aliaga, Pamela, Del Signore, Ester, Asnaghi, Riccardo, Carnevale Schianca, Ambra, Passaro, Antonio, de Marinis, Filippo

Volltext

The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics von Trillo Aliaga, Pamela, Del Signore, Ester, Fuorivia, Valeria, Spitaleri, Gianluca, Asnaghi, Riccardo, Attili, Ilaria, Corvaja, Carla, Carnevale Schianca, Ambra, Passaro, Antonio, de Marinis, Filippo

Volltext

Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario von Fuorivia, Valeria, Attili, Ilaria, Corvaja, Carla, Asnaghi, Riccardo, Carnevale Schianca, Ambra, Trillo Aliaga, Pamela, Del Signore, Ester, Spitaleri, Gianluca, Passaro, Antonio, de Marinis, Filippo

Volltext

Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? von Spitaleri, Gianluca, Trillo Aliaga, Pamela, Attili, Ilaria, Del Signore, Ester, Corvaja, Carla, Corti, Chiara, Crimini, Edoardo, Passaro, Antonio, de Marinis, Filippo

Volltext

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung c... von Attili, Ilaria, Valenza, Carmine, Santoro, Celeste, Antonarelli, Gabriele, Trillo Aliaga, Pamela, Del Signore, Ester, Catania, Chiara, Spitaleri, Gianluca, Passaro, Antonio, de Marinis, Filippo

Volltext

Solitude and fear during the great coronavirus war von Catania, Chiara, Del Signore, Ester, gianoncelli, letizia

Volltext

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond von Gori, Bruno, Ricciardi, Serena, Fulvi, Alberto, Intagliata, Salvatore, Del Signore, Ester, de Marinis, Filippo

Volltext

Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model von de Marinis, Filippo, Attili, Ilaria, Morganti, Stefania, Stati, Valeria, Spitaleri, Gianluca, Gianoncelli, Letizia, Del Signore, Ester, Catania, Chiara, Rampinelli, Cristiano, Omodeo Salè, Emanuela, Spaggiari, Lorenzo, Mastrilli, Fabrizio, Passaro, Antonio

Volltext

Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis von Attili, Ilaria, Asnaghi, Riccardo, Vacirca, Davide, Adorisio, Riccardo, Rappa, Alessandra, Ranghiero, Alberto, Lombardi, Mariano, Corvaja, Carla, Fuorivia, Valeria, Carnevale Schianca, Ambra, Trillo Aliaga, Pamela, Spitaleri, Gianluca, Del Signore, Ester, Guarize, Juliana, Spaggiari, Lorenzo, Guerini-Rocco, Elena, Fusco, Nicola, de Marinis, Filippo, Passaro, Antonio

Volltext

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy von Longo, Flavia, Mansueto, Giovanni, Lapadula, Vittoria, De Sanctis, Rita, Quadrini, Silvia, Grande, Roberta, Gori, Bruno, Altavilla, Amelia, D’Antoni, I., Del Signore, Ester, Stumbo, Luciano, De Luca, Cristina, Cimadon, Barbara, Cortesi, Enrico, Gamucci, Teresa, Di Seri, Marisa

Volltext